Neoleukin Therapeutics Inc (NLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLTX | AZN | AMGN | GILD | BMY |
| Company | Neoleukin Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.45 | 178.70 | 347.08 | 126.69 | 55.80 |
| High | 3.59 | 180.44 | 349.40 | 128.20 | 56.21 |
| Low | 3.42 | 177.65 | 338.90 | 124.11 | 55.01 |
| Latest | 3.49 | 177.89 | 341.66 | 125.45 | 55.28 |
| Change | +0.05 | -0.82 | -6.18 | -1.78 | -0.64 |
| % Change | +1.45% | -0.46% | -1.78% | -1.40% | -1.14% |
| Volume | 113,100 | 1,868,600 | 3,470,300 | 7,726,700 | 8,968,500 |
| 20-Day Average Volume | 33,865 | 2,014,065 | 2,828,325 | 8,349,146 | 11,619,825 |
| Previous Close | 3.44 | 178.71 | 347.84 | 127.23 | 55.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.45 | 182.41 | 341.08 | 129.16 | 56.72 |
| 20-Day Raw Stochastic | 62.00% | 19.47% | 53.54% | 25.68% | 17.85% |
| 20-Day Relative Strength | 50.56 | 43.07 | 49.81 | 42.38 | 44.17 |
| Weighted Alpha | +35.60 | +18.02 | +15.39 | +9.17 | +15.28 |
| Today's Opinion | 72% Sell | 56% Sell | 24% Buy | 72% Sell | 24% Sell |
| Previous Opinion | 96% Sell | 56% Sell | 40% Buy | 56% Sell | 24% Sell |
| Last Month's Opinion | 88% Sell | 24% Sell | 40% Sell | 24% Sell | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.29% since 12/11/23 | -0.60% since 06/10/26 | +1.16% since 06/10/26 | +3.27% since 06/10/26 | -0.58% since 06/10/26 |
| Low | 3.25 on 12/12/23 | 176.55 on 06/15/26 | 338.90 on 06/17/26 | 121.79 on 06/11/26 | 55.01 on 06/17/26 |
| High | 3.64 on 12/15/23 | 183.67 on 06/11/26 | 358.46 on 06/11/26 | 128.20 on 06/17/26 | 57.60 on 06/12/26 |
| 1-Month | |||||
| %Chg | +4.18% since 11/17/23 | -2.03% since 05/15/26 | +4.70% since 05/15/26 | -3.19% since 05/15/26 | -3.02% since 05/15/26 |
| Low | 3.18 on 11/22/23 | 174.60 on 06/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 54.20 on 06/02/26 |
| High | 3.68 on 11/30/23 | 191.50 on 05/21/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 60.25 on 05/22/26 |
| 3-Month | |||||
| %Chg | -9.35% since 09/18/23 | -7.01% since 03/17/26 | -5.39% since 03/17/26 | -13.12% since 03/17/26 | -7.42% since 03/17/26 |
| Low | 3.18 on 11/22/23 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 54.20 on 06/02/26 |
| High | 4.14 on 10/10/23 | 207.30 on 04/10/26 | 360.68 on 03/18/26 | 143.79 on 03/18/26 | 62.22 on 04/01/26 |
| 6-Month | |||||
| %Chg | -9.84% since 06/16/23 | -1.02% since 12/17/25 | +4.80% since 12/17/25 | +3.37% since 12/17/25 | +3.23% since 12/17/25 |
| Low | 3.05 on 08/14/23 | 174.60 on 06/03/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 4.70 on 07/17/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,799 | 277,162,784 | 187,732,032 | 157,964,944 | 114,192,608 |
| Shares Outstanding, K | 9,398 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -57,560,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -4,530,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.11 | 0.25 | 0.42 | 0.31 | 0.24 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/14/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 03/19/24 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.14 | 15.86 | 14.85 | 9.48 |